Docoh
Loading...

SENS Senseonics

News

From Benzinga Pro
Senseonics Holdings, Inc. Common Stock Q3 EPS $0.10 Beats $(0.06) Estimate, Sales $3.50M Miss $3.52M Estimate
9 Nov 21
Earnings, News
Senseonics Holdings, Inc. Common Stock (AMEX:SENS) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.06) by 266.67 percent. This is a 200 percent increase over losses of
How Bad Are Senseonics Holdings Common Stock's Earnings? | Return On Capital Employed
9 Nov 21
Earnings
Benzinga Pro data, Senseonics Holdings, Inc. Common Stock (AMEX:SENS) reported Q2 sales of $3.29 million. Earnings fell to a loss of $15.89 million, resulting in a 31.34% decrease from last quarter. Senseonics Holdings, Inc.
Earnings Scheduled For November 9, 2021
9 Nov 21
Earnings, M&A, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.
Watching Shares Of ContextLogic, Senseonics, Romeo Power, Vinco Ventures, Bitfarms Following Pennystocks.com Article '5 Short Squeeze Penny Stocks To Watch Today'
28 Oct 21
Media, Trading Ideas
https://pennystocks.com/featured/2021/10/28/5-short-squeeze-penny-stocks-to-watch-today/
18 Stocks Moving in Tuesday's Pre-Market Session
21 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44 million.
Senseonics Announces Collaboration With University Hospitals Accountable Care Organization In Cleveland, Ohio
13 Sep 21
News, Contracts
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with

Press releases

From Benzinga Pro
Senseonics Holdings, Inc. Reports Third Quarter 2021 Financial Results
9 Nov 21
Press Releases
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today
Senseonics to Participate in Upcoming November Investor Conferences
8 Nov 21
Press Releases
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today
Thinking about buying stock in Creatd, Sundial Growers, Progenity, IZEA Worldwide, or Senseonics Holdings?
22 Oct 21
Opinion, Press Releases
NEW YORK, Oct. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRTD, SNDL, PROG, IZEA, and SENS.
Thinking about buying stock in Nextplay Technologies, Sio Gene Therapies, Kadmon, Senseonics, or InMed Pharmaceuticals?
21 Oct 21
Opinion, Press Releases
NEW YORK, Oct. 21, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NXTP, SIOX, KDMN, SENS, and INM.
Thinking about buying stock in Plug Power, Senseonics, Up Fintech, Waitr Holdings, or Ocugen?
14 Oct 21
Small Cap, Opinion, Press Releases
NEW YORK, Oct. 14, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PLUG, SENS, TIGR, WTRH, and OCGN.
Senseonics Announces Equity Grants To Employees Under Inducement Plan
4 Oct 21
Press Releases
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes,
Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio
13 Sep 21
Press Releases
--The University Hospitals Accountable Care Organization places patients on the Eversense CGM System Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and commercialization
Senseonics to Participate in the H.C. Wainwright Global Investment Conference
9 Sep 21
Press Releases
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today